-
Wholly Remote COVID-19 Drug Trial Gets High Marks On Operational Front
Clinical Research News | A fully remote randomized clinical trial, born of necessity in the early days of the pandemic, provides evidence that the study model is viable even when testing drugs with potential heart rhythm effects. Whether the concept will be as well embraced post-pandemic remains anyone’s guess.
Mar 9, 2022
-
Sponsors Validating Multiple Digital Endpoints For Clinical Trials
Clinical Research News | The development and validation of novel digital endpoints in clinical trials was the subject of several case studies shared at the recent Summit for Clinical Ops Executives (SCOPE), including a pilot study of a speech-language assessment tool by Regeneron Pharmaceuticals and trials of at-home monitoring devices for gait speed and nocturnal scratching by Pfizer. Rapid adoption of wearables has provided opportunities to innovate and better understand patients and biomarkers of health abnormalities
Mar 7, 2022
-
Fast Track Designation for Myeloid Checkpoint Inhibitor, Neuromodulation for Heart Failure, Digital Twins in Trials, More
Clinical Research News | A first-in-class myeloid checkpoint inhibitor was granted fast track designation, clinical trial results are in for vagus nerve stimulation to treat heart failure, a clinical trial launches to assess glycosaminoglycan profiling as all-cancer detection method, and new agreements have been entered or extended to promote decentralized trials and the use of digital twins
Mar 2, 2022
-
Rules And Roles Of Decentralized Clinical Trials Coming Into View
Clinical Research News | The current regulatory landscape for decentralized clinical trials (DCTs), and a trio of use cases focused on medical devices and in vitro diagnostic (IVD) products, were among a bevy of presentations on the decentralized study model at the recent Summit for Clinical Research Ops Executives (SCOPE).
Mar 1, 2022
-
Follow the Money: Immunological Therapeutics, Signal Regulatory Protein-Targeting Therapeutics, Regulatory Compliance Technology
Clinical Research News | New pharma-focused venture cap fund, funding to drive trials for treating immunological and inflammatory diseases and shingles, and more.
Feb 28, 2022
